For this year Gilead Sciences's revenue will be around 24,2 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue of 22,45 billion USD.
The analysts expect for 2020 a net profit of 8,8 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 6,99 USD. The price/earnings-ratio is then 9,01.
Gilead Sciences's market capitalization is based on the number of outstanding shares around 80,71 billion USD. The Gilead Sciences stock was the past 12 months quite unstable. Since last October the stock is 0 percent lower. This year the stock price moved between 62 and 86 dollar.
Click here for dividend Gilead Sciences. At 16.36 the stock trades 0,48 percent lower at 62,96 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.